Regardless of the precise underlying mechanism, an impressive number of genetic animal models now demonstrate a role for the inflammasome in mediating IL-1β-induced insulin resistance. This is further supported by earlier intervention studies showing that IL-1 blockade in animal models of diabetes improved both insulin secretion and sensitivity.
